semaglutide eye pain Tied to Increased Risk of Serious Disease Semaglutide Associated With Optic Neuropathy

Nausea, reduced appetite, constipation, diarrhoea, and general gastrointestinal discomfort can affect work, exercise, and mood during dose escalation

Patel L, Cooper CD, Quinton ND, Butler GE, Gill MS, Jefferson IG, et al

After tracking his biomarkers, he ultimately stopped his microdosing protocol, reporting that it had increased his resting heart rate and negatively affected his sleep

This effect is preserved in patients with type-2 diabetes and a number of GLP-1-based therapies are approved or in late stage clinical trials for treatment of this disease 2,3

Germany GLP-1 Drugs Market Trends The use of GLP-1 drugs in Germany is increasing due to growing incidences of type 2 diabetes as well as obesity

Clinical trials show 510 pounds of loss by 12 weeks for most patients, with some achieving 15+ pounds depending on starting weight and lifestyle factors